drugset / Trial / NCT02139826

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

NCT02139826 ↗

Phase 1 Completed 12 enrolled Ixchelsis Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the absorption and blood levels of IX-01 when given as a capsule compared to liquid form, and how food affects the absorption in healthy men.

Timeline

Start
2014-05
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject IX-01 Unknown 800 mg —

Indications

No indication recorded.